Abstract
The high prevalence of hypertension and the long-term of antihypertensive treatments required are the main reasons for the need of economic analysis on the costs of hypertensive treatment. This study aims to quantify direct medical cost of hypertension. This study uses retrospective cost of illness analysis in descriptive observational design with heath care perspective. Data were collected from the hospital’s management information system, patient's prescriptions and patient's medical records. Fifty-eight patient’s data were analyzed. Direct medical cost of the patient without comorbidities in stage 1 hypertension was Rp 535,660 ± 100,681, stage 2 hypertension was Rp 381,940 ± 126,423 and hypertensive crises was Rp 456,241 ± 197,959. Direct medical cost of the patients with comorbidities in stage 1 hypertension was Rp 398,750 ± 240,542, stage 2 hypertension was Rp 486,227 ± 241,136 and hypertensive crises was Rp 425,816 ± 140,898. Direct medical costs for patients with compelling indications in stage 1 hypertension was Rp 512,810 ± 152,661, stage 2 hypertension was Rp 444,183 ± 109,162 and hypertensive crises was Rp 410,364 ± 80,388. Cost for drugs was represented as the largest component of direct medical cost (37.49%) followes by cost for ward (26.54%), medical treatment fee (15.88%), medical support fee (9.05%), doctor visit fee (8.12%) and service fee (2.91%). The hypertension's stage, comorbidities and compelling indications are not affecting the cost of therapy. The rational use of drugs will decrease the cost of hypertension treatment.
Highlights
PENDAHULUAN Evaluasi ekonomi sudah berkembang menjadi bagian penting dalam bidang pelayanan kesehatan
This study aims to quantify direct medical cost of hypertension
N.W., Mukaddas, A., dan Tandah, M.R., 2016, Analisis Efektifitas Biaya Pengobatan
Summary
Penetapan Populasi Populasi target dalam penelitian ini adalah semua data pasien rawat inap di RSUDD Praya tahun 2016. Populasi terjangkau adalah data pasien yang dirawat inap di RSUD Praya periode JanuariDesember tahun 2016. Kriteria Inklusi dan Eksklusi Kriteria inklusi dalam penelitian ini adalah pasien RSUD Praya dengan diagnosis utama hipertensi; pasien usia di atas 18 tahun; tidak dalam keadaan hamil; bukan pasien dengan kanker atau terinfeksi human immunodeficiency virus (HIV); bukan pasien yang keluar rumah sakit dengan keterangan pulang paksa, dirujuk atau meninggal dunia. Kriteria eksklusi dalam penelitian ini adalah pasien dengan data kurang lengkap, hilang atau tidak terbaca. Biaya medis langsung ditampilkan dalam satuan rata-rata per hari dan standar deviasinya
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
